ArisGlobal to Attend and Speak on Regulatory Data at GPRAS in Berlin

Apr 1, 2022

In person attendance, speaking session, and LifeSphere Regulatory demos mark the life sciences software leader’s return to the convention circuit.

MIAMI, April 1 – ArisGlobal®, the leading provider of life sciences software that automates core drug development functions with its end-to-end technology platform LifeSphere®, today announces its attendance at the Global Pharma Regulatory Affairs Summit (GPRAS) in Berlin, Germany, April 6-8, 2022.

GPRAS is the only conference leading the way in IDMP, RIM, Global E-Submissions, and Regulatory Affairs in global markets. With guidance directly from regulatory authorities and industry leaders, providing insights into policy and real-world case studies to help you achieve your compliance goals.

Jim Hilferty, a 20-year life sciences industry professional with specific focus on regulatory products and services will be speaking in a dedicated session regarding regulatory data.

Robin Schilling, a 15-year global technology implementation professional and member of the IRISS IDMP Working Group, will be on hand at ArisGlobal’s event booth to discuss LifeSphere’s Regulatory product capabilities.

Session details:

Speaker: Jim Hilferty
Title: Regulatory Data: Empowering Teams to Drive Efficiencies Across the Drug Development Lifecycle
Date/Time: April 7, 2022, 12PM CET

For additional information on ArisGlobal’s attendance, or to schedule an in person meeting, please visit the ArisGlobal GPRAS information page.

LATEST NEWS

Additional Information

Connect with ArisGlobal on LinkedIn: linkedin.com/company/aris-global
Follow @Aris_Global on Twitter: twitter.com/aris_global

Contact

Erika Thomas
ArisGlobal
+305-726-6601 | ethomas@arisglobal.com

About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn: linkedin.com/company/aris-global
Follow @Aris_Global on Twitter: twitter.com/aris_global

Contact

Erika Thomas
ArisGlobal
+305-726-6601 | ethomas@arisglobal.com